Expression Analysis (EA), a provider of genomic services for clinical trials and research, has received CLIA (Clinical Laboratory Improvement Act) certification.

EA achieves the milestone as the company enters its tenth year of providing genomic expertise referred to as ‘Genomic Know-How’.

EA president and CEO Steve McPhail said they are excited about the addition of clinical laboratory testing to their service offerings and this certification further validates EA’s operational and organizational excellence.

"For ten years EA has delivered exceptional services and our clients have come to expect the highest quality work with the ability to overcome challenging scientific hurdles. With this certification, our clients can be confident of our continued commitment to their success," McPhail said.

Expression Analysis provides whole genome to focus set gene expression and genotyping assays along with DNA sequencings services, sequence enrichment technologies and bioinformatics support.